News

Exploring Market Movements: Arista Networks and Its Traders

Exploring Market Movements: Arista Networks and Its Traders

Understanding Arista Networks Trading Activity

Recently, significant investors have shown a notable bearish interest in Arista Networks. Our detailed analysis of options history for Arista Networks (ANET) has revealed 17 unusual trades, reflecting contrasting trader sentiment.

Trader Sentiment Breakdown

Among the trades, we observed that 23% were bullish, while a majority of 58% indicated bearish tendencies. Specifically, we identified 3 put trades totaling $135,650, while 14 call trades reached a value of $992,854.

Projected Price Range for Arista Networks

The trading patterns suggest that influential investors aim for a price range between $60.0 and $125.0 for Arista Networks over the last three months. This expected price target frames the outlook for the stock amidst current market conditions.

Volume and Open Interest Insights

Examining volume and open interest offers crucial insights into trader intentions and market liquidity. This data serves as a tool for tracking interest in Arista Networks' options at predetermined strike prices.

Recent Trading Highlights for Arista Networks

Below, we summarize the trends observed in volume and open interest for call and put options, reflecting Arista Networks' whale activities within the price range of $60.0 to $125.0 over the past month.

Noteworthy Options Trades Recorded

Significant options trades are a vital indicator of market sentiment:

Symbol: ANET | Trade Type: CALL | Sentiment: BULLISH | Expiration Date: 01/16/26 | Ask: $12.6 | Bid: $12.2 | Price: $12.5 | Strike Price: $90.00 | Total Trade Price: $250.0K | Open Interest: 1.0K | Volume: 200

Symbol: ANET | Trade Type: CALL | Sentiment: BULLISH | Expiration Date: 04/17/25 | Ask: $2.7 | Bid: $2.65 | Price: $2.7 | Strike Price: $90.00 | Total Trade Price: $107.1K | Open Interest: 1.4K | Volume: 7

Symbol: ANET | Trade Type: CALL | Sentiment: NEUTRAL | Expiration Date: 01/16/26 | Ask: $12.5 | Bid: $12.2 | Price: $12.34 | Strike Price: $90.00 | Total Trade Price: $99.9K | Open Interest: 1.0K | Volume: 282

About Arista Networks

Arista Networks is a leading provider of networking equipment, specializing in Ethernet switches and software solutions tailored for data centers. The company was established in 2004 and has successfully carved out a strong market presence with its innovative extensible operating system (EOS). Major clients such as Microsoft and Meta Platforms account for a significant share of its revenue, with approximately three-fourths of its sales emanating from North America.

Current Market Dynamics for Arista Networks

  • With a trading volume of 1,510,930, the price of ANET currently stands at $81.55, reflecting a 3.06% increase.
  • Recent RSI values suggest the stock may be experiencing an oversold condition, indicating potential buying opportunities.
  • The next earnings report is anticipated in approximately 55 days, which could further influence stock performance.

Analysts’ Perspectives on Arista Networks

Recent assessments from five market analysts indicate a consensus target price of $120.4 for ANET, reflecting optimism about its future performance.

Have you ever wondered if trading options can lead to quick profits?

With an experienced trader’s one-line chart technique, you could potentially turn a $1000 investment into $1270 within just 20 days by applying specific strategies. These trades have historically gained an average profit of around 27% over this period.

For further insights, an analyst from Barclays continues to endorse an Overweight rating for Arista Networks with a price target of $126. Meanwhile, Rosenblatt's analyst holds a Sell rating with a target of $85. Citigroup maintains a Buy rating, aiming for a target of $121. Wells Fargo also has a positive outlook, with a target of $125, while Goldman Sachs remains optimistic with a Buy rating and a price target as high as $145.

Engaging in options trading entails both risks and rewards. Successful traders invest in ongoing education, adjust their strategies accordingly, and stay informed with real-time market updates and alerts.

Frequently Asked Questions

What is the current price of Arista Networks (ANET)?

The current price of ANET is approximately $81.55, with a recent increase of 3.06%.

How do options trades reflect market sentiment?

Options trades can indicate the sentiment of traders regarding future price movements, showing whether they are bullish or bearish on a stock.

What are the expected price targets for ANET?

Analysts have projected price targets for ANET ranging from $85 to $145, reflecting a spectrum of sentiment among experts.

How can I track Arista Networks' trading volume and open interest?

Tracking trading volume and open interest provides insights into market liquidity and trader interest in specific options and strike prices.

What is the importance of analysts’ ratings for a stock?

Analysts’ ratings offer guidance on potential investment strategies and price expectations, helping investors make informed decisions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 313

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 193

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 128

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 130

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 224

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 332

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 134

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 541

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 161

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading

Top 5 Most Recently Viewed Articles

Phreesia Announces Q3 Fiscal Year 2025 Financial Results

Updated Category News Views 71

Phreesia to Release Fiscal Q3 2025 Results Soon Phreesia, Inc. (NYSE: PHR) has great news for its stakeholders! The company revealed plans to announce its financial results for the third quarter of fiscal year 2025 right after market closing on a Monday in December. During this quarter, the firm experienced substantial growth and is eager to share the details with the...

Continue Reading
Innovative Water Bowl Design Enhances Pet Hydration Experience

Updated Category News Views 374

Revolutionary Pet Water Bowl Crafted for Optimal Hydration Every pet owner knows the importance of keeping their furry friends hydrated, especially during hot days. A new invention promises to enhance the experience for pets and their owners alike. This innovative water bowl, known as the THERMA DRINK, is designed with features that cater directly to pet needs. The idea...

Continue Reading
HPH's Leadership Changes Signify Strategic Direction Ahead

Updated Category News Views 177

Leadership Transitions at HPH Highest Performances Holdings Inc. (NASDAQ: HPH) has recently seen a notable change in its Board of Directors. The company announced that Mr. Peh Chin Hua's tenure as Director has come to an end, effective immediately. This decision is part of a broader strategy aimed at strengthening the Board's overall composition and capabilities. Current...

Continue Reading
Apranga Group Reports Growth in Retail Turnover for 2025

Updated Category News Views 132

Apranga Group Retail Performance Overview for 2025 Apranga Group, a major player in the retail sector, has announced its impressive financial performance for the first six months of 2025, demonstrating notable growth compared to the prior year. The company's retail turnover reached a commendable EUR 166.1 million, reflecting a 2.8% increase from the same period in 2024....

Continue Reading
IMUNON Unveils Promising New Vaccine Data for COVID-19

Updated Category News Views 154

New Vaccine Insights from IMUNON's Phase 1 Clinical Trial The innovative PlaCCine technology platform developed by IMUNON, Inc. (NASDAQ: IMNN) promises remarkable durability and advantages over traditional mRNA vaccines, particularly in the struggle against COVID-19. Robust Results from IMNN-101 Vaccine Trials In an encouraging announcement, IMUNON shared pivotal data...

Continue Reading